Tag: biopharma
“There is a growing trend towards outsourcing clinical trials to India”
Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research Limited shares his vision for the company, latest developments, long-term growth, industry trends and future outlook
BioVoice eMagazine December 2024 | Issue 8 | Volume 5
The Cover Story features the India’s 10 Biggest Bioscience Stories of the year 2024. Read interviews of Supriya Kashikar, Founder & CEO, GeNext Genomics; and Ankit Alok Bagaria, Co- Founder, Loopworm. Expert Insights by Niteen Tulpule, Director, Orthobiologix Biotech; Chander Shekhar Sibal, Vice President & Head of Division, Medical Systems Division, FUJIFILM India; and Nilesh Aggarwal, CEO, IJCP Group & Founder, Medtalks.
Biologic therapies mark progress in severe asthma treatment & remission potential:...
While biologics have shown great promise, barriers such as cost, access, and insurance coverage limit their availability, particularly in underserved communities
CPHI & PMEC India 2024 showcases over 10,000 pharma products
Over 50,000 global industry professionals, including key decision-makers, gathered at the event to explore new partnerships and growth opportunities
India gets its first indigenous antibiotic ‘Nafithromycin’ to combat drug resistance
New antibiotic offers 10x efficacy with just 3 doses to combat drug-resistant pneumonia
Delhi -NCR all set to host CPHI & PMEC India on...
The Expo will bring together over 50000 visitors and 2000 exhibitors providing a unique environment for industry experts to share ideas and drive their business forward
BioVoice eMagazine November 2024 | Issue 7 | Volume 5
The Cover Story tracks the strides made by the Indian biotech industry towards sustainability goals. Special interview of Shivaji Dashrath Jadhav, Vice President & Head - EHS & Sustainability, Aragen Life Sciences. Expert Insights by Vikrant Agrawal, Co-founder, Care.fi and Rajeev Taneeja, Founder and CEO, Global Care. Special stories on bio-manufacturing, healthcare innovation and agri-foodtech.
Emcure Pharma records Rs 2,002 crore operational revenue with 20% revenue...
EBITDA margins at 20.8% with EBITDA up 26.1% YoY and 15.8% QoQ
IL-35-Mediated Immunotherapy: A new treatment for Type I & autoimmune diabetes...
The growing global diabetes epidemic that disproportionately affects developing country children and adolescents calls for effective treatment for the disease
Top 20 global biopharma players witness 2% growth in market capitalization...
Industry leaders are driving innovation by advancing their R&D pipelines and entering billion-dollar strategic alliances






























































